InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Castelein Caley, Director. Director active across 3 companies, notably ViewRay, Inc.. Aggregated, 10 filings have been logged. Total volume traded: €6.6m. The latest transaction was disclosed on 13 June 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations10 total
054,511 shares0
Common Stock
SEC:0001628280-22-017230:0·
€854,118350,000 shares@ €2.440386.9% of flow
Common Stock
SEC:0001628280-22-014015:0·
Ideal exit: 4 Feb 2023 (T+270)
€64,18212,521 shares@ €5.126100.0% of flow
Common Stock
SEC:0001628280-22-000344·
€64,18212,521 shares@ €5.1266.5% of flow
Common Stock
SEC:0001628280-22-000344:0·
€3m259,998 shares@ €11.1233100.0% of flow
Common Stock
SEC:0000899243-21-034553·
Ideal exit: 23 May 2022 (T+270)
€3m259,998 shares@ €11.123350.0% of flow
Common Stock
SEC:0000899243-21-034553:0·
Ideal exit: 23 May 2022 (T+270)
€10,0137,811 shares@ €1.282100.0% of flow
Common Stock
SEC:0000899243-21-027286·
€10,0137,811 shares@ €1.28250.0% of flow
Common Stock
SEC:0000899243-21-027286:0·
019,759 shares0
Common Stock
SEC:0001209191-21-040911·
019,759 shares0
Common Stock
SEC:0001209191-21-040911:0·
10 of 10 declarations
About Castelein Caley
Caley Castelein is a Director at ViewRay, Inc., Aerpio Pharmaceuticals, Inc., and Aadi Bioscience, Inc. In this role, she participates in the governance of all three companies and in strategic decision-making. Her experience in the biotechnology sector is valuable for these companies.
